FDA Inspection 1068720 - Worldwide Clinical Trials Early Phase Services, LLC - October 17, 2018

FDA Inspection 1068720 for Worldwide Clinical Trials Early Phase Services, LLC on October 17, 2018. Classification: Voluntary Action Indicated (VAI).

View on Dashboard

One-time purchase from the GKS catalog. Lifetime access in your library. Single documents and full company profiles available. All sales final.

Record Summary

FDA Inspection 1068720 for Worldwide Clinical Trials Early Phase Services, LLC on October 17, 2018. Classification: Voluntary Action Indicated (VAI).

Violation Codes

21 CFR 312.60

Get More Insights

Access our comprehensive regulatory intelligence platform to analyze patterns, track compliance trends, and stay ahead of regulatory changes.

1.5M+ regulatory data points

Real-time compliance monitoring

Interactive analytics dashboard

Looking for more records? Our platform provides access to thousands of similar regulatory documents with advanced search and filtering capabilities.

Record Information

Company

Worldwide Clinical Trials Early Phase Services, LLC

Inspection Date

October 17, 2018

Product Type

Drugs

Office

Center for Drug Evaluation and Research

ID: 55c43fd7-2317-41ec-adca-44aea67a0ff1

View on Dashboard

Transform Regulatory Data into Actionable Intelligence

Join leading pharmaceutical and medical device companies who trust GKS for their regulatory compliance needs.

Try KeyPedia Today

Explore our real use cases and discover our features in depth.

Subscribe to our newsletter

Get the latest updates and insights delivered to your inbox